Publications by authors named "L J S Kelliher"

Chemosensory cells across the body of Drosophila melanogaster evaluate the environment to prioritize certain behaviors. Previous mapping of gustatory receptor neurons (GRNs) on the fly labellum identified a set of neurons in L-type sensilla that express Ionotropic Receptor 94e (IR94e), but the impact of IR94e GRNs on behavior remains unclear. We used optogenetics and chemogenetics to activate IR94e neurons and found that they drive mild feeding suppression but enhance egg laying.

View Article and Find Full Text PDF

Low-grade serous ovarian cancer was previously thought to be a subtype of high-grade serous ovarian cancer, but it is now recognized as a distinct disease with unique clinical and molecular behaviors. The disease may arise de novo or develop from a serous borderline ovarian tumor. Although it is more indolent than high-grade serous ovarian cancer, most patients have advanced metastatic disease at diagnosis and recurrence is common.

View Article and Find Full Text PDF

Background: Adequate iodine status is critical for thyroid hormone synthesis, which is essential for foetal brain development. Suboptimal iodine status has been reported in young women across Europe. Although urinary iodine concentration (UIC) is a good indicator of recent exposure, it does not reflect habitual iodine intake.

View Article and Find Full Text PDF
Article Synopsis
  • Serous borderline tumors (SBT) are ovarian lesions generally associated with a good prognosis, but 10-15% can progress to low-grade serous cancer (LGSC), which is aggressive and resistant to standard chemotherapy.
  • The research uses a combination of spatial proteomics and transcriptomics to understand the transition from SBT to LGSC, identifying an intermediary stage with micropapillary features (SBT-MP) and increased MAPK signaling.
  • Key findings include the discovery of specific proteins and transcripts linked to tumor invasiveness, alongside a blueprint for future studies on tumorigenesis and potential new treatment approaches for ovarian cancer.
View Article and Find Full Text PDF

High-grade serous ovarian cancer (HGSOC) is the deadliest subtype of ovarian cancer, and most patients do not survive more than 5 years after diagnosis. Yet, for reasons that are often elusive, approximately 15% of women with advanced-stage HGSOC will survive longer than 10 years. An understanding of the biological basis of long-term survival with HGSOC may elucidate novel prognostic factors and targets for treatment.

View Article and Find Full Text PDF